Febbo Phillip G.
Chief Scientific & Med Officer
Febbo Phillip G. has filed 8 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Febbo Phillip G. is listed as Chief Scientific & Med Officer at VERACYTE, INC. Inside the rolling window, Febbo Phillip G. reported no open-market purchases and 2 open-market sales totaling $1.0M in VCYT. The largest disclosed transaction in the window is a sale of 13,110 VCYT shares on Sep 4, 2026, worth $564K.
Companies traded
Other insiders at VCYT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 6, 2025 | VCYT | Sale | $301K |
Frequently asked questions
How many SEC Form 4 filings has Febbo Phillip G. made?
Febbo Phillip G. has filed 8 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Febbo Phillip G. trade?
Febbo Phillip G. has filed SEC Form 4 disclosures for 1 company, including VCYT.
When was Febbo Phillip G.'s most recent SEC Form 4 filing?
Febbo Phillip G.'s most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Febbo Phillip G.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Febbo Phillip G. is listed as Chief Scientific & Med Officer.
What is Febbo Phillip G.'s total buy and sell value in the current window?
Inside the rolling retention window, Febbo Phillip G. bought $0 and sold $1.0M based on SEC Form 4 filings.
What was Febbo Phillip G.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 13,110 VCYT shares on 2026-09-04, worth $564K, per SEC Form 4 filings.